Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease

Journal of Pediatrics

Volumn 141, Issue 4, 2002, Pages 560-565

  Wang, Chih Lu ^a   Wu, Yu Tsun ^a   Lee, Chia Jung ^a   Liu, Hsiu Chin ^a   Huang, Li Tung ^a   Yang, Kuender D ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MESSENGER RNA; NITRIC OXIDE;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG EFFECT; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INFLAMMATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; URINALYSIS; VASCULITIS;

EID: 0036796870     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.127505     Document Type: Article

References (24)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Jpn J Allergy 1967;16:178-222.
2. Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, et al. Kawasaki disease: a brief history. Pediatrics 2000;106:E27.
3. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P. Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1995;87:1776-80.
4. Meissner HC, Leung DY. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr Infect 2000;19:91-4.
5. Leung DY, Schlievert PM, Meissner HC. The immunopathogenesis and management of Kawasaki syndrome. Arthritis Rheum 1998;41:1538-47.
6. Iizuka T, Oishi K, Sasaki M, Hatanaka Y, Minatogawa Y, Uemura S, et al. Nitric oxide and aneurysm formation in Kawasaki disease. Acta Paediatr 1997;86:470-3.
7. Tsukahara H, Kikuchi K, Matsuda M, Saito M, Hata I, Tsuchida S, et al. Endogenous nitric oxide production in Kawasaki disease. Scand J Clin Lab Invest 1997;57:43-7.
8. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998;41:1141-51.
9. Kroncke KD, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 1998;113:147-56.
10. Annane D, Sanquer S, Sebille V, Faye A, Djuranovic D, Raphael JC, et al. Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 2000;355:1143-8.
11. Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 1995;91:2982-8.
12. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 2001;89:224-36.
13. Wang CL, Su MH, Chao TY, Shaio MF, Yang KD. When do human macrophages release nitric oxide? Variable effects of certain in vitro cultural and in vivo resident conditions. Proc Natl Sci Council ROC 1996;20:65-70.
14. Ajayi AA. Estimation of creatinine clearance from serum creatinine: utility of the Cockroft and Gault equation in Nigerian patients. Eur J Clin Pharmacol 1991;40:429-31.
15. Waller DG, Fleming JS, Ramsey B, Gray J. The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate. Postgrad Med J 1991;67:42-6.
16. Desjardin LE, Chen Y, Perkins MD, Teixeira L, Cave MD, Eisenach KD. Comparison of the ABI 7700 system (TagMan) and competitive PCR for quantification of 1S6100 DNA in sputum during treatment of tuberculosis. J Clin Microbiol 1998;36:1964-8.
17. Chen RF, Yeh WT, Yang MY, Yang KD. A model of the real time correlation of viral titers with immune reaction in antibody-dependent enhancement of dengue-2 infections. FEMSIM 2000;1278:1-7.
18. Herbertson A, Aubin JE. Cell sorting enriches osteogenic populations in rat bone marrow stromal cell cultures. Bone 1997;21:491-500.
19. Ichiyama T, Yoshitomi T, Nishikawa M, Fujiwara M, Matsubara T, Hayashi T, et al. NF-κB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol 2001;99:373-7.
20. Pan MH, Lin-Shiau SY, Lin JK. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of 1kappaB kinase and NFκB activation in macrophages. Biochem Pharmacol 2000;60:1665-76.
21. Liu SF, Ye X, Malik AB. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 1997;159:3976-83.
22. Osorio JC, Xu X, Vogel T, Ochoa M, Laycock S, Hintze TH. Plasma nitrate accumulation during the development of pacing-induced dilated cardiac myopathy in conscious dogs is due to renal impairment. Nitric Oxide 2001;5:7-17.
23. Sriskandan S, Evans TJ, Cohen J. Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-gamma. J Immunol 1996; 156: 2430-5.
24. 2+ movements and nitric oxide production in endothelial cells. J Biol Chem 1996;271:26473-6.